B-Smart Hepatitis

 

B-SMART: Hepatitis B Webcast
(Non-CME)

Print this Content

 

Hepatitis B virus (HBV) remains a major infection worldwide. 
Despite the overwhelming success of immunization, in the United States 1.2 million are infected, due in large measure to immigrants from high endemic areas. This series is intended for hepatologists, gastroenterologists, infectious disease physicians, primary care physicians, infectious disease and gastroenterology nurse practitioners, infection control nurses, physician assistants, and others involved with the health care of HBV patients or those at increased risk for acquiring the infection.

    Read More >>

Watch Introduction by Dr. Carey
Understanding Cultural Barriers
Estimated Time: 15 minutes
Release Date: January 15, 2009
Type: Webcast
Technical Requirements: Windows Media
Specialties: Gastroenterology, Infectious Disease, Family Practice, Hepatology

Series Objectives

  1. Summarize the epidemiologic and natural history of hepatitis B.
  2. Translate emerging clinical trial data as it relates to hepatitis B practice guidelines.
  3. List methods for raising awareness of the importance of HBV prevention through immunization.
  4. Identify cultural barriers to management of HBV infection in Asian Americans and detail strategies to overcome the barriers.
  5. Compare and contrast therapeutic profiles for drug classes approved to treat hepatitis B infection, including data on combination therapies.

Activity Director

William D. Carey, MD
Professor of Medicine
Cleveland Clinic Lerner College of Medicine
Department of Gastroenterology Hepatology
Digestive Disease Institute
Cleveland Clinic
Cleveland, OH

 
Copyright © 2000-2017 The Cleveland Clinic Foundation. All Rights Reserved.
Center for Continuing Education | 1950 Richmond Road, TR204, Lyndhurst, OH 44124
Copyright © 2000-2017 The Cleveland Clinic Foundation. All Rights Reserved.
Center for Continuing Education | 1950 Richmond Road, TR204, Lyndhurst, OH 44124